147 related articles for article (PubMed ID: 6226978)
1. [Comparison of various types of islet cell antibodies in diabetes as a function of its cause and duration].
Vialettes B; Di Campo-Rougerie C; Lassmann V; Vague P
Presse Med; 1983 Oct; 12(37):2303-6. PubMed ID: 6226978
[TBL] [Abstract][Full Text] [Related]
2. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
3. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
4. Quantitative estimation of islet cell surface antibodies in sera of patients with diabetes mellitus, using BK virus-induced insulinoma, rat islet or fish islet cells and 125I-antihuman IgG antibody.
Negishi K; Kawazu S; Ishii J; Kanazawa Y
J Clin Lab Immunol; 1986 Apr; 19(4):155-9. PubMed ID: 3014151
[TBL] [Abstract][Full Text] [Related]
5. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children.
Gerling I; Baekkeskov S; Lernmark A
J Immunol; 1986 Dec; 137(12):3782-5. PubMed ID: 3537124
[TBL] [Abstract][Full Text] [Related]
6. A new ELISA assay for islet cell surface antibodies determination in type 1 diabetes mellitus of recent onset.
Bizzarro A; De Bellis A; Florio A; Gentile S; Amoresano Paglionico V; Cacciatore F; Iacono G
Horm Metab Res Suppl; 1992; 26():119-20. PubMed ID: 1490676
[TBL] [Abstract][Full Text] [Related]
7. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
Majkowska L; Czekalski S; Skwira J
Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
[TBL] [Abstract][Full Text] [Related]
8. Islet cell cytoplasmic and surface antibodies' prevalence and beta cell specificity of islet cell surface antibodies in some subjects with putative islet cell autoimmunity.
Keilacker H; Hildmann W; Wassmann C; Schade J; Kohnert KD; Strese J; Michaelis D; Ziegler M
Biomed Biochim Acta; 1984; 43(5):657-61. PubMed ID: 6383370
[TBL] [Abstract][Full Text] [Related]
9. Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.
Bruining GJ; Molenaar J; Tuk CW; Lindeman J; Bruining HA; Marner B
Diabetologia; 1984 Jan; 26(1):24-9. PubMed ID: 6368297
[TBL] [Abstract][Full Text] [Related]
10. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
11. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.
Dobersen MJ; Scharff JE; Ginsberg-Fellner F; Notkins AL
N Engl J Med; 1980 Dec; 303(26):1493-8. PubMed ID: 7001237
[TBL] [Abstract][Full Text] [Related]
13. Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.
Millward A; Hussain MJ; Peakman M; Pyke DA; Leslie RD; Vergani D
Clin Exp Immunol; 1988 Feb; 71(2):353-6. PubMed ID: 3127094
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes.
Sensi M; Zuccarini O; Spencer KM; Beales P; Pujol-Borrell R; Pozzilli P
Diabetes Res; 1985 Jan; 2(1):1-4. PubMed ID: 3888494
[TBL] [Abstract][Full Text] [Related]
15. Islet cell surface antibodies by an ELISA method in diabetic and nondiabetic patients.
Betterle C; Presotto F; Magrin L; Caretto A; Pedini B; Zanchetta R
J Endocrinol Invest; 1991 Apr; 14(4):293-7. PubMed ID: 1865079
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics.
Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S
Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893
[TBL] [Abstract][Full Text] [Related]
18. Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies.
Omar MA; Srikanta S; Eisenbarth GS
Diabetes Res; 1987 Apr; 4(4):155-7. PubMed ID: 3304781
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous IgG subclass distribution of islet cell antibodies.
Dozio N; Belloni C; Girardi AM; Genovese S; Sodoyez JC; Bottazzo GF; Pozza G; Bosi E
J Autoimmun; 1994 Feb; 7(1):45-53. PubMed ID: 8198701
[TBL] [Abstract][Full Text] [Related]
20. Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells.
Van De Winkel M; Smets G; Gepts W; Pipeleers D
J Clin Invest; 1982 Jul; 70(1):41-9. PubMed ID: 6123526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
